Rule 144 filing: Celestica (NYSE: CLS) holder targets 120,000-share sale

Rhea-AI Filing Summary

Celestica Inc. insider plans a Rule 144 stock sale. A holder has filed to sell 120,000 Celestica common shares through Janney Montgomery Scott LLC / Stirling Wealth Management on the NYSE, with an aggregate market value of $33,103,200.00. The approximate sale date indicated is February 5, 2026, and Celestica had 115,036,621 common shares outstanding.

The shares to be sold come from prior equity awards. They were received upon vesting of share units from Celestica Inc. in four transactions: 90,643 shares on February 4, 2026; 10,852 shares on December 2, 2025; 15,575 shares on February 2, 2023; and 2,930 shares on February 1, 2023, each settled as common shares.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Janney Montgomery Scott LLC / Stirling Wealth Managemen 2200 Georgetown Drive Suite 400 Sewickley PA 15143	120000	33103200.00	115036621	02/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	02/04/2026	Shares received in settlement of share units upon vesting	Celestica Inc.			90643	02/04/2026	N/A
Common Shares	12/02/2025	Shares received in settlement of share units upon vesting	Celestica Inc.			10852	12/02/2025	N/A
Common Shares	02/02/2023	Shares received in settlement of share units upon vesting	Celestica Inc.			15575	02/02/2023	N/A
Common Shares	02/01/2023	Shares received in settlement of share units upon vesting	Celestica Inc.			2930	02/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Celestica (CLS) Form 144 filing disclose?

The Form 144 discloses a plan to sell 120,000 Celestica common shares under Rule 144. The proposed sale, valued at $33,103,200.00, will be executed through Janney Montgomery Scott LLC on the NYSE, with an approximate sale date of February 5, 2026.

How many Celestica (CLS) shares are planned for sale and what is their value?

The filing plans for the sale of 120,000 Celestica common shares with an aggregate market value of $33,103,200.00. These shares are to be sold on the NYSE through Janney Montgomery Scott LLC / Stirling Wealth Management as broker.

When is the planned sale date for the Celestica (CLS) shares under Rule 144?

The Form 144 lists an approximate sale date of February 5, 2026 for the 120,000 Celestica common shares. This timing reflects when the holder expects to begin selling the shares on the NYSE through the named broker.

How were the Celestica (CLS) shares to be sold originally acquired?

All shares were acquired as equity compensation, received in settlement of share units upon vesting from Celestica Inc. They were delivered in four tranches on February 4, 2026, December 2, 2025, February 2, 2023, and February 1, 2023 as common shares.

What prior equity award vesting events are detailed in the Celestica (CLS) filing?

The filing lists four vesting events: 90,643 shares on February 4, 2026; 10,852 shares on December 2, 2025; 15,575 shares on February 2, 2023; and 2,930 shares on February 1, 2023. Each event reflects settlement of share units into common shares.

How many Celestica (CLS) common shares were outstanding when the Rule 144 notice was prepared?

The document notes that 115,036,621 Celestica common shares were outstanding. This figure provides context for the planned 120,000-share sale, indicating the broader equity base against which the transaction occurs.